This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

WILLIAM E. COSTOLOW, M.D.; WILLIAM R. WISDOM, M.D.

AMA Arch Surg. 1955;70(2):199-202.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE MATERIAL for this article was collected over the years 1930 through 1953 at the Los Angeles Tumor Institute (Drs. Costolow, Meland, Johnson, Nolan, and Hare), and patients were referred by urologists and surgeons for postoperative radiation therapy. Seventy-three patients with retroperitoneal tumors were accepted for treatment. In some instances, the postoperative treatment was given immediately after surgery, and in others it was commenced only after recurrences or metastases had occurred. This caused a wide variation in the stage of disease, the tumor dosage, and the survival rate. With such diversity of cases, it is impossible to obtain survival percentages of statistical significance. It is our belief, however, that demonstrable regression of tumor and increased survival time after postoperative irradiation, or irradiation alone in the case of inoperable tumors, do demonstrate the value of these modalities. The widely varied origin and histology of these tumors make prognosis difficult. In many . . . [Full Text PDF of this Article]

Author Affiliations
Los Angeles

Fellow in Radiation Therapy, Albert Soiland Cancer Foundation (Dr. Wisdom).

Footnotes
Read in the Symposium on Retroperitoneal Tumors before the Joint Meeting of the Section on Radiology and the Section on Urology at the 103rd Annual Meeting of the American Medical Association.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?